Not Yet Recruiting
Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease
NCT07625384
- Conditions
- Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
- Locations
-
- Republic Clinical and Diagnostic Center of the Ministry of Health of the Udmurt Republic Izhevsk, Russia
- "Vashe Zdorovie" Research Medical Complex, LLC Kazan', Russia
- Family Clinic No. 4, LLC Korolyov, Russia
- Limited Liability Company "OLLA-MED" Moscow, Russia